BILLS-109hr6303ih.pdf

23:48 Oct 04, 2006 VerDate Aug 31 2005 30 days 90 days 13 days 1984 ANNUAL 3-year SEPTEMBER 29, 2006 3 years 15 days each day 15 days

SESSION H. R. 6303 the ‘‘Access, Compassion

Tier II PO 00000 Frm PO 00000 Frm 00001 PO 00000 Frm 00011 PO 00000 Frm 00006 PO 00000 Frm 00020 PO 00000 Frm 00016 PO 00000 Frm 00017 PO 00000 Frm 00010 PO 00000 Frm 00019 PO 00000 Frm 00021 Fmt PO 00000 Frm 00022 PO 00000 Frm 00023 Fmt PO 00000 Frm 00009 PO 00000 Frm 00024 Fmt PO 00000 Frm 00012 PO 00000 Frm 00015 Tier III PO 00000 Frm 00008 Fmt PO 00000 Frm 00007 PO 00000 Frm 00018 PO 00000 Frm 00004

the United States of America the United States

Cosmetic

HMBILLS SEC the Federal Food, Drug Committee uct Accelerated Approval Advisory Committee Food and Drug Administration the Food and Drug Administration Drug Administration Approval Advisory Committee Drugs the Federal Food the Committee Advisory Committee TIMELINE.—The Committee The Accelerated Approval Advisory Committee ONCOLOGY PARTICIPATION.—Any THE HOUSE OF REPRESENTATIVES National Cancer Institute the Accelerated Approval Advisory the Committee on the statutory GENERAL.—The Committee the Public Health Service State CONTENT.—A the Office of the 7 Congress MITTEE ISTRATION House of Representa- the Food and Drug Adminis- the Institute of Medicine THE FOOD AND DRUG ADMIN- the General Schedule the Commissioner of Food and Drugs the Committee review MEETINGS.—A the Committee of all Tier I Energy and Commerce Tier I the Oncology Drugs Advisory 4 Committee Senate Drug

SHAYS REVIEW.—If

tier ill seriously approval patients food drug clinical threatening devices biological drugs food products drug drug administration